OBJECTIVE

To identify associations between weight status and clinical outcomes in children with lower respiratory tract infection (LRTI) or asthma requiring hospitalization.

METHODS

We performed a retrospective cohort study of 2 to 17 year old children hospitalized for LRTI and/or asthma from 2009 to 2019 using electronic health record data from the PEDSnet clinical research network. Children <2 years, those with medical complexity, and those without a calculable BMI were excluded. Children were classified as having underweight, normal weight, overweight, or class 1, 2, or 3 obesity based on Body Mass Index percentile for age and sex. Primary outcomes were need for positive pressure respiratory support and ICU admission. Subgroup analyses were performed for children with a primary diagnosis of asthma. Outcomes were modeled with mixed-effects multivariable logistic regression incorporating age, sex, and payer as fixed effects.

RESULTS

We identified 65 132 hospitalizations; 6.7% with underweight, 57.8% normal weight, 14.6% overweight, 13.2% class 1 obesity, 5.0% class 2 obesity, and 2.8% class 3 obesity. Overweight and obesity were associated with positive pressure respiratory support (class 3 obesity versus normal weight odds ratio [OR] 1.62 [1.38–1.89]) and ICU admission (class 3 obesity versus normal weight OR 1.26 [1.12–1.42]), with significant associations for all categories of overweight and obesity. Underweight was also associated with positive pressure respiratory support (OR 1.39 [1.24–1.56]) and ICU admission (1.40 [1.30–1.52]).

CONCLUSIONS

Both underweight and overweight or obesity are associated with increased severity of LRTI or asthma in hospitalized children.

Asthma and lower respiratory tract infections (LRTI), including community-acquired pneumonia (CAP), viral pneumonia, and bronchiolitis, are common reasons for hospitalization. The prevalence of obesity continues to increase for children, reaching 18.5% overall in 2016.1,2  In developing countries, malnutrition has been associated with poor outcomes from respiratory infections.3  Findings from research investigating associations between weight status and clinical outcomes from respiratory disease vary.

There are many potential reasons that children with obesity could have poor clinical outcomes from respiratory diseases, including reduced lung function, increased inflammatory response, provider implicit or explicit bias against patients with obesity, and difficulties in the physical exam.46  These issues may be exacerbated for children with severe obesity.7  Asthma, especially, may have a distinct phenotype and present with more severe exacerbations in children with obesity.811  Reduced access to primary care previously associated with pediatric obesity could affect disease severity at presentation, hospital length of stay (LOS), and readmission rates.12  However, the existing literature investigating clinical outcomes in this population has significant limitations. Large, well-powered studies in children hospitalized for LRTI and asthma rely on administrative coding for obesity, often underestimating obesity prevalence; additionally, they may lack detailed clinical data needed to assess health outcomes accurately.1318  Single-site studies of pediatric patients using measured body weight are limited by small sample size and minimal geographic variability.8,9,11,19  In contrast, patients with underweight could have underlying comorbidities, micronutrient deficiencies, associated immunodeficiency, or susceptibility to different organisms that impact the course of their respiratory illness.3 

To overcome limitations in the existing literature, we obtained measured anthropometric data for children hospitalized for asthma, bronchiolitis, CAP, and/or viral pneumonia at multiple geographically diverse sites within the United States using the PEDSnet clinical data research network. The objective of our study was to identify associations between weight status and outcomes of hospitalization for LRTI and asthma, specifically need for positive pressure respiratory support (ie, continuous positive airway pressure, bilevel positive airway pressure, or mechanical ventilation), admission to an ICU, hospital LOS, and readmissions. We hypothesized that children with obesity would have increased disease severity, which would increase their risk for advanced respiratory support, ICU admission, and prolonged LOS, compared to children with normal weight.

We performed a retrospective cohort study using data from the PEDSnet clinical research network (https://pedsnet.org/). PEDSnet institutions share electronic health record and other clinical data to rapidly accelerate pediatric evidence generation. The PEDSnet data from this study came from 6 major children’s health systems across the United States. The different health systems vary in size, with the smallest contributing 1.6% and the largest 26.4% of hospital encounters for this cohort. This study was determined to qualify for exemption from human subjects review by our local institutional review board.

We identified children ages 2 to 18 years evaluated in the emergency department and subsequently hospitalized at participating sites between January 1, 2009 and November 30, 2019 with any diagnosis code of bronchiolitis, viral pneumonia, asthma, or CAP. Although we did not anticipate many children in this age group would be diagnosed with bronchiolitis, we included the diagnosis to optimize our capture of children with respiratory illness and to be consistent with previous literature.20,21  To identify the diagnoses of interest, we started with previously published literature of International Classification of Diseases, 9th Revision, Clinical Modification codes (Supplemental Table 3),20,21  which were translated to the appropriate Systematized Nomenclature of Medicine Clinical Terms codes (Supplemental Table 4). Since only Systematized Nomenclature of Medicine Clinical Terms codes were used to query the PEDSnet database, the transition to International Classification of Diseases, 10th Revision, Clinical Modification coding did not affect our search strategy. We excluded children with complex chronic conditions defined by the Pediatric Medical Complexity Algorithm Version 3.0, because these children are expected to have different growth patterns than children without medical complexity.22  Asthma and obesity are diagnoses included in this algorithm but were not used to exclude children for this study. We also excluded children without documented BMI within 3 months of the index encounter. Overweight and obesity are not consistently defined in children <2 years, and patients >18 years are not consistently admitted to children’s hospitals; therefore, these children were excluded.23,24 

Data obtained from the PEDSnet database included dates of encounters, anthropometrics, diagnoses, demographics, and procedure codes. Payer was categorized as public, private or military, or none. Some encounters had multiple payers listed; in that case, the hierarchical order chosen was private or military (if available), followed by public (if available), followed by none. Diagnoses were categorized as asthma, bronchiolitis, CAP, and viral pneumonia and flagged if listed as the primary diagnosis for that encounter. For the primary exposure, we used the height and weight from the index emergency department (ED) visit to compute BMI. If either height or weight or both were not recorded during the index ED visit, we selected the closest available recorded weight ± 90 days of the index encounter followed by any height obtained ± 60 days of the weight measurement to minimize selection bias. We used age on the date of the encounter, sex, and BMI to classify the child’s weight per Centers for Disease Control and Prevention guidelines as follows: <5%ile underweight, 5%ile to <85%ile normal weight, 85%ile to <95%ile overweight, 100% to <120% of 95%ile class 1 obesity, 120% to <140% of 95%ile class 2 obesity, and >140% of 95%ile class 3 obesity.7,23,24  Outliers were identified by CDC guidelines and excluded.25  Age was categorized as 2 to 5 years, 6 to 11 years, and 12 to 18 years.

Our outcome measures assessed severity of illness, measured by receipt of positive pressure ventilation (continuous positive airway pressure, bilevel positive airway pressure, or mechanical ventilation) during the hospital stay, ICU admission at any point during the hospitalization, and hospital LOS. We were unable to assess nasal cannula or high-flow nasal cannula use in this data set. In addition, we assessed 7- and 30- day ED revisits and 7- and 30-day hospital readmissions for asthma, bronchiolitis, CAP, or viral pneumonia.

We defined an asthma subgroup for this analysis, which included all patients with a primary diagnosis of asthma. We expected those patients to be managed primarily for an asthma exacerbation during their hospital admission, which was corroborated by review of medications (specifically bronchodilators) administered during the hospitalization. In addition, we defined subgroups for CAP and for viral pneumonia and bronchiolitis, which included children with those listed as primary or secondary diagnoses.

Results were analyzed initially using descriptive statistics to determine the prevalence of overweight and obesity among children by demographic and clinical characteristics, including age, sex, race and ethnicity, payer, and respiratory diagnosis. Bivariate comparisons between groups were done by using χ2 tests for proportions and analysis of variance procedures for continuous variables. Along with our primary exposure of BMI category, we included age, sex, and payer in a mixed effects multivariable logistic regression model, which treated site, patient, and year of admission as random effects. The outcome of LOS was modeled using Poisson regression, both unadjusted and adjusted for age category, sex, and payer. A 2-sided P value of .05 was used as the cutoff for statistical significance. Sensitivity analyses were performed with all payer data from site D set to missing, given known loss of data at that site due to electronic health record migration during the study period. Additionally, sensitivity analyses were performed by using only data from sites C, F, and G, which had the lowest percentages of missing BMI data. All analyses were performed at the encounter level using SAS version 9.4 (SAS Institute, Cary, NC).

We identified 47 693 children who met our inclusion and exclusion criteria, as shown in Fig 1; of those, 6.7% had underweight, 57.8% normal weight, 14.6% overweight, 13.2% class 1 obesity, 5.0% class 2 obesity, and 2.8% class 3 obesity (obesity class groupings are exclusive of each other). These patients had a total of 65 132 hospitalizations during the study period; demographic and clinical information for all encounters in this cohort are shown in Table 1. The distribution of children with any diagnosis of CAP (P < .01), any diagnosis of viral pneumonia or bronchiolitis (P < .01), and a primary diagnosis of asthma (P < .01) differed between weight categories. Clinical and demographic information for the subgroup of children with primary asthma are shown in Supplemental Table 5.

FIGURE 1

Cohort identification (patient-level data).

FIGURE 1

Cohort identification (patient-level data).

Close modal
TABLE 1

Clinical and Demographic Data for Full Cohort (Encounter-Level Data)

Underweight (%) (N = 4356)Normal Wt (%) (N = 37 631)Overweight (%) (N = 9489)Class 1 (%) (N = 8586)Class 2 (%) (N = 3254)Class 3 (%) (N = 1816)P
Age
2–5 y
6–11 y
12–18 y 
2798 (64.2)
1015 (23.3)
543 (12.5) 
18 149 (48.2)
11 585 (30.8)
7897 (21.0) 
3550 (37.4)
3286 (34.6)
2653 (28.0) 
3209 (37.4)
2906 (33.9)
2471 (28.8) 
571 (17.6)
1245 (38.3)
1438 (44.2) 
143 (7.9)
697 (38.4)
976 (53.7) 
<.01 
Male sex 2644 (60.7) 21 598 (57.4) 5200 (54.8) 4912 (57.2) 1746 (53.7) 914 (50.3) <.01 
Race and ethnicity
White
Black
Hispanic
Asian
Other 

1854 (42.6)
1304 (29.9)
537 (12.3)
235 (5.4)
426 (9.8) 

14 513 (38.6)
14 198 (37.7)
4928 (13.1)
1174 (3.1)
2818 (7.5) 

3331 (35.1)
3844 (40.5)
1385 (14.6)
209 (2.2)
720 (7.6) 

2808 (32.7)
3575 (41.6)
1388 (16.2)
182 (2.1)
633 (7.4) 

989 (30.4)
1487 (45.7)
483 (14.8)
72 (2.2)
223 (6.9) 

502 (27.6)
984 (54.2)
203 (11.2)
23 (1.3)
104 (5.7) 
<.01 
Insurancea
Private or military
Public
None 

1520 (34.9)
2130 (48.9)
272 (6.2) 

11 436 (30.4)
18 269 (48.6)
2289 (6.1) 

2512 (26.5)
4965 (52.3)
511 (5.4) 

2029 (23.6)
4736 (55.2)
457 (5.3) 

740 (22.7)
1790 (55.0)
193 (5.9) 

356 (19.6)
981 (54.0)
131 (7.2) 
<.01 
Community-acquired pneumonia diagnosis 404 (9.3) 2270 (6.0) 458 (4.8) 426 (5.0) 139 (4.3) 66 (3.6) <.01 
Bronchiolitis or viral pneumonia diagnosis 1207 (27.7) 5705 (15.2) 974 (10.3) 871 (10.1) 176 (5.4) 65 (3.6) <.01 
Primary diagnosis of asthma 1961 (45.0) 19 878 (52.8) 5008 (52.8) 4583 (53.4) 1696 (52.1) 913 (50.3) <.01 
Hospital LOS (days), mean (SD), median (IQR)** 3.4 (13.2)
2 (1–3) 
2.6 (5.6)
2 (1–3) 
2.7 (5.5)
2 (1–3) 
2.9 (5.9)
2 (1–3) 
2.7 (5.4)
2 (1–3) 
2.9 (4.2)
2 (1–3) 
<.01 
ICU admission 855 (19.6) 5487 (14.6) 1541 (16.2) 1428 (16.6) 500 (15.4) 296 (16.3) <.01 
Intubation or ventilation 381 (8.8) 2325 (6.2) 650 (6.9) 624 (7.3) 234 (7.2) 164 (9.0) <.01 
7-d ED revisit 265 (6.1%) 2418 (6.4) 667 (7.0%) 645 (7.5) 267 (8.2) 135 (7.4) <.01 
30-d ED revisit 571 (13.1%) 5180 (13.8) 1452 (15.3%) 1365 (15.9) 612 (18.8) 301 (16.6) <.01 
7-d hospital readmission 77 (1.8%) 582 (1.6) 167 (1.8%) 178 (2.1) 76 (2.3) 45 (2.5) <.01 
30-d hospital readmission 241 (5.5%) 2004 (5.3) 608 (6.4%) 584 (6.8) 287 (8.8) 145 (8.0) <.01 
Underweight (%) (N = 4356)Normal Wt (%) (N = 37 631)Overweight (%) (N = 9489)Class 1 (%) (N = 8586)Class 2 (%) (N = 3254)Class 3 (%) (N = 1816)P
Age
2–5 y
6–11 y
12–18 y 
2798 (64.2)
1015 (23.3)
543 (12.5) 
18 149 (48.2)
11 585 (30.8)
7897 (21.0) 
3550 (37.4)
3286 (34.6)
2653 (28.0) 
3209 (37.4)
2906 (33.9)
2471 (28.8) 
571 (17.6)
1245 (38.3)
1438 (44.2) 
143 (7.9)
697 (38.4)
976 (53.7) 
<.01 
Male sex 2644 (60.7) 21 598 (57.4) 5200 (54.8) 4912 (57.2) 1746 (53.7) 914 (50.3) <.01 
Race and ethnicity
White
Black
Hispanic
Asian
Other 

1854 (42.6)
1304 (29.9)
537 (12.3)
235 (5.4)
426 (9.8) 

14 513 (38.6)
14 198 (37.7)
4928 (13.1)
1174 (3.1)
2818 (7.5) 

3331 (35.1)
3844 (40.5)
1385 (14.6)
209 (2.2)
720 (7.6) 

2808 (32.7)
3575 (41.6)
1388 (16.2)
182 (2.1)
633 (7.4) 

989 (30.4)
1487 (45.7)
483 (14.8)
72 (2.2)
223 (6.9) 

502 (27.6)
984 (54.2)
203 (11.2)
23 (1.3)
104 (5.7) 
<.01 
Insurancea
Private or military
Public
None 

1520 (34.9)
2130 (48.9)
272 (6.2) 

11 436 (30.4)
18 269 (48.6)
2289 (6.1) 

2512 (26.5)
4965 (52.3)
511 (5.4) 

2029 (23.6)
4736 (55.2)
457 (5.3) 

740 (22.7)
1790 (55.0)
193 (5.9) 

356 (19.6)
981 (54.0)
131 (7.2) 
<.01 
Community-acquired pneumonia diagnosis 404 (9.3) 2270 (6.0) 458 (4.8) 426 (5.0) 139 (4.3) 66 (3.6) <.01 
Bronchiolitis or viral pneumonia diagnosis 1207 (27.7) 5705 (15.2) 974 (10.3) 871 (10.1) 176 (5.4) 65 (3.6) <.01 
Primary diagnosis of asthma 1961 (45.0) 19 878 (52.8) 5008 (52.8) 4583 (53.4) 1696 (52.1) 913 (50.3) <.01 
Hospital LOS (days), mean (SD), median (IQR)** 3.4 (13.2)
2 (1–3) 
2.6 (5.6)
2 (1–3) 
2.7 (5.5)
2 (1–3) 
2.9 (5.9)
2 (1–3) 
2.7 (5.4)
2 (1–3) 
2.9 (4.2)
2 (1–3) 
<.01 
ICU admission 855 (19.6) 5487 (14.6) 1541 (16.2) 1428 (16.6) 500 (15.4) 296 (16.3) <.01 
Intubation or ventilation 381 (8.8) 2325 (6.2) 650 (6.9) 624 (7.3) 234 (7.2) 164 (9.0) <.01 
7-d ED revisit 265 (6.1%) 2418 (6.4) 667 (7.0%) 645 (7.5) 267 (8.2) 135 (7.4) <.01 
30-d ED revisit 571 (13.1%) 5180 (13.8) 1452 (15.3%) 1365 (15.9) 612 (18.8) 301 (16.6) <.01 
7-d hospital readmission 77 (1.8%) 582 (1.6) 167 (1.8%) 178 (2.1) 76 (2.3) 45 (2.5) <.01 
30-d hospital readmission 241 (5.5%) 2004 (5.3) 608 (6.4%) 584 (6.8) 287 (8.8) 145 (8.0) <.01 
a

Missing insurance data (434 underweight, 5637 normal, 1501 overweight, 1364 class 1, 531 class 2, 348 class 3) among hospitalized children with COVID-19. Hosp Pediatr. 2021;11(11):e297-e316.

Our primary outcome was severity of illness, measured by need for positive pressure ventilation and ICU care. Figure 2 demonstrates associations between BMI category and positive pressure ventilation following mixed effects multivariable logistic regression. Class 3 obesity had the strongest associations in both the full cohort (odds ratio [OR] 1.62, 95% confidence interval [CI] 1.38–1.89) and in the subgroup with a primary diagnosis of asthma (OR 1.65, 95% CI 1.33–2.06); no association was seen with class 2 or 3 obesity in the CAP or viral pneumonia or bronchiolitis subgroups. Statistically significant associations were seen for overweight and class 1 obesity in all four cohorts. Underweight had a positive association in the full cohort (OR 1.39, 95% CI 1.24–1.56) and the viral pneumonia or bronchiolitis subgroup (OR 1.19, 95% CI 1.00–1.41), but no associations were seen in the asthma or CAP subgroups.

FIGURE 2

Associations between BMI category (reference normal weight) and positive pressure ventilation for (a) the entire cohort, (b) the subgroup with a primary diagnosis of asthma, (c) the subgroup with any diagnosis of community-acquired pneumonia, and (d) the subgroup with any diagnosis of viral pneumonia or bronchiolitis.

FIGURE 2

Associations between BMI category (reference normal weight) and positive pressure ventilation for (a) the entire cohort, (b) the subgroup with a primary diagnosis of asthma, (c) the subgroup with any diagnosis of community-acquired pneumonia, and (d) the subgroup with any diagnosis of viral pneumonia or bronchiolitis.

Close modal

Figure 3 demonstrates associations between BMI category and ICU care. For this outcome, the strongest associations were found with underweight for both the full cohort (OR 1.40, 95% CI 1.30–1.52) and the asthma subgroup (OR 1.41, 95% CI 1.26–1.59). In contrast, the strongest associations were found with class 3 obesity for the CAP subgroup (OR 1.82, 95% CI 1.05–3.13) and the viral pneumonia or bronchiolitis subgroup (OR 1.68, 95% CI 1.00–2.81). As seen above with respiratory support, overweight and class 1 obesity had statistically significant associations across all four cohorts. In addition, we performed sensitivity analyses to verify that known issues with insurance data from 1 site as well as the degree of missing BMI data overall did not impact our results; minimal differences in the multivariable models were noted in those sensitivity analyses (Supplemental Tables 5 and 6).

FIGURE 3

Associations between BMI category (reference normal weight) and ICU admission for (a) the entire cohort, (b) the subgroup with a primary diagnosis of asthma, (c) the subgroup with any diagnosis of community-acquired pneumonia, and (d) the subgroup with any diagnosis of viral pneumonia or bronchiolitis.

FIGURE 3

Associations between BMI category (reference normal weight) and ICU admission for (a) the entire cohort, (b) the subgroup with a primary diagnosis of asthma, (c) the subgroup with any diagnosis of community-acquired pneumonia, and (d) the subgroup with any diagnosis of viral pneumonia or bronchiolitis.

Close modal

Associations with hospital LOS are shown in Table 2. After both unadjusted and adjusted analyses, the strongest associations in the full cohort were seen with underweight, with coefficients 0.27 (95% CI 0.25–0.29) and 0.32 (95% CI 0.30–0.33), respectively. Differences in LOS between other weight categories, which range from 2.6 to 2.9 days, seem unlikely to be clinically significant even though some statistically significant associations were found. In each of the subgroup analyses, stronger positive associations were seen with obesity rather than with underweight.

TABLE 2

Associations Between BMI Category (Reference Normal wt) and Hospital LOS Both Unadjusted and Adjusted for Age Category, Sex, and Payer for (a) the Entire Cohort and (b) the Subgroup With a Primary Diagnosis of Asthma, (c) the Subgroup with CAP, and (d) the Subgroup with Viral Pneumonia or Bronchiolitis

a) Entire Cohort
BMI Category Length of Stay Median (IQR) Unadjusted Coefficient (95% CI) Adjusted Coefficient (95% CI) 
Underweight 2 (1–3) 0.27 (0.25–0.29) 0.32 (0.30–0.33) 
Normal wt 2 (1–3) Reference Reference 
Overweight 2 (1–3) 0.03 (0.02–0.04) −0.01 (−0.02–0.01) 
Class 1 obesity 2 (1–3) 0.09 (0.07–0.10) 0.04 (0.03–0.06) 
Class 2 obesity 2 (1–3) 0.02 (0.00–0.04) −0.09 (−0.11 to −0.06) 
Class 3 obesity 2 (1–3) 0.09 (0.06–0.12) −0.05 (−0.08 to −0.02) 
b) Subgroup With Asthma 
BMI Category Length of Stay Median (IQR) Unadjusted Coefficient (95% CI) Adjusted Coefficient (95% CI) 
Underweight 2 (1–3) 0.03 (0.00–0.07) 0.06 (0.02–0.09) 
Normal wt 2 (1–3) Reference Reference 
Overweight 2 (1–3) 0.04 (0.02–0.06) 0.02 (0.00–0.04) 
Class 1 obesity 2 (1–3) 0.10 (0.07–0.12) 0.07 (0.05–0.10) 
Class 2 obesity 2 (1–3) 0.16 (0.12–0.19) 0.10 (0.06–0.13) 
Class 3 obesity 2 (1–3) 0.22 (0.17–0.26) 0.13 (0.08–0.18) 
c) Subgroup With CAP 
BMI Category Length of Stay Median (IQR) Unadjusted Coefficient (95% CI) Adjusted Coefficient (95% CI) 
Underweight 3 (2–5) 0.13 (0.08–0.18) 0.14 (0.09–0.18) 
Normal wt 2 (1–4) Reference Reference 
Overweight 3 (1–5) 0.24 (0.20–0.29) 0.18 (0.13–0.22) 
Class 1 obesity 2.5 (1.0–5.0) 0.37 (0.33–0.41) 0.31 (0.27–0.35) 
Class 2 obesity 2 (1–5) 0.26 (0.19–0.33) 0.16 (0.09–0.23) 
Class 3 obesity 3 (2–5) 0.11 (0.00–0.22) −0.11 (−0.22–0.00) 
d) Subgroup With Viral Pneumonia or Bronchiolitis 
BMI Category Length of Stay Median (IQR) Unadjusted Coefficient (95% CI) Adjusted Coefficient (95% CI) 
Underweight 2 (1–4) 0.16 (0.13–0.19) 0.18 (0.15–0.21) 
Normal wt 2 (1–4) Reference Reference 
Overweight 2 (1–4) 0.06 (0.02–0.09) 0.00 (−0.03–0.04) 
Class 1 obesity 3 (2–4) 0.24 (0.21–0.28) 0.20 (0.16–0.23) 
Class 2 obesity 2.5 (1.5–4.0) 0.43 (0.36–0.50) 0.29 (0.23–0.36) 
Class 3 obesity 3 (2–6) 0.50 (0.39–0.60) 0.19 (0.08–0.29) 
a) Entire Cohort
BMI Category Length of Stay Median (IQR) Unadjusted Coefficient (95% CI) Adjusted Coefficient (95% CI) 
Underweight 2 (1–3) 0.27 (0.25–0.29) 0.32 (0.30–0.33) 
Normal wt 2 (1–3) Reference Reference 
Overweight 2 (1–3) 0.03 (0.02–0.04) −0.01 (−0.02–0.01) 
Class 1 obesity 2 (1–3) 0.09 (0.07–0.10) 0.04 (0.03–0.06) 
Class 2 obesity 2 (1–3) 0.02 (0.00–0.04) −0.09 (−0.11 to −0.06) 
Class 3 obesity 2 (1–3) 0.09 (0.06–0.12) −0.05 (−0.08 to −0.02) 
b) Subgroup With Asthma 
BMI Category Length of Stay Median (IQR) Unadjusted Coefficient (95% CI) Adjusted Coefficient (95% CI) 
Underweight 2 (1–3) 0.03 (0.00–0.07) 0.06 (0.02–0.09) 
Normal wt 2 (1–3) Reference Reference 
Overweight 2 (1–3) 0.04 (0.02–0.06) 0.02 (0.00–0.04) 
Class 1 obesity 2 (1–3) 0.10 (0.07–0.12) 0.07 (0.05–0.10) 
Class 2 obesity 2 (1–3) 0.16 (0.12–0.19) 0.10 (0.06–0.13) 
Class 3 obesity 2 (1–3) 0.22 (0.17–0.26) 0.13 (0.08–0.18) 
c) Subgroup With CAP 
BMI Category Length of Stay Median (IQR) Unadjusted Coefficient (95% CI) Adjusted Coefficient (95% CI) 
Underweight 3 (2–5) 0.13 (0.08–0.18) 0.14 (0.09–0.18) 
Normal wt 2 (1–4) Reference Reference 
Overweight 3 (1–5) 0.24 (0.20–0.29) 0.18 (0.13–0.22) 
Class 1 obesity 2.5 (1.0–5.0) 0.37 (0.33–0.41) 0.31 (0.27–0.35) 
Class 2 obesity 2 (1–5) 0.26 (0.19–0.33) 0.16 (0.09–0.23) 
Class 3 obesity 3 (2–5) 0.11 (0.00–0.22) −0.11 (−0.22–0.00) 
d) Subgroup With Viral Pneumonia or Bronchiolitis 
BMI Category Length of Stay Median (IQR) Unadjusted Coefficient (95% CI) Adjusted Coefficient (95% CI) 
Underweight 2 (1–4) 0.16 (0.13–0.19) 0.18 (0.15–0.21) 
Normal wt 2 (1–4) Reference Reference 
Overweight 2 (1–4) 0.06 (0.02–0.09) 0.00 (−0.03–0.04) 
Class 1 obesity 3 (2–4) 0.24 (0.21–0.28) 0.20 (0.16–0.23) 
Class 2 obesity 2.5 (1.5–4.0) 0.43 (0.36–0.50) 0.29 (0.23–0.36) 
Class 3 obesity 3 (2–6) 0.50 (0.39–0.60) 0.19 (0.08–0.29) 

Although 7- and 30-day ED revisit and hospital readmission prevalence was higher for children with overweight or obesity, these findings remained consistent only for the 30-day outcomes in the multivariable regression models, as shown in Supplemental Table 7.

Using data from 6 geographically diverse children’s health systems, we found that children with underweight and those with overweight or obesity were more likely to receive positive pressure respiratory support and ICU admission when hospitalized with asthma or LRTI. In the full cohort, underweight, but not overweight or obesity, was associated with a longer hospital LOS, whereas obesity was associated with an increase in 30 day ED revisits and hospital readmissions. To our knowledge, this is the first large multicenter study in the United States to evaluate these associations using measured anthropometrics.

We found that underweight, overweight, and obesity were associated with positive pressure respiratory support, with a dose-dependent increase with increasing obesity. This remained relatively consistent across our subgroup analyses. This finding corroborates a previous study using the Kids Inpatient Database, in which obesity was associated with the use of mechanical ventilation in hospitalized children with a diagnosis of bronchitis or pneumonia (adjusted OR 2.90, 95% CI 2.15–3.90).13  In that study, children with obesity were identified solely by administrative coding with cohort prevalence of obesity of 1.1%; the larger effect size seen in that study could be explained by clinicians being more likely to diagnose obesity in children with more severe obesity, in whom stronger associations with this outcome might be expected. In contrast, one previous small study of children admitted with influenza-like illness did not find significant associations between overweight or obesity and prolonged LOS or oxygen requirement; however, the study may have been underpowered to detect these outcomes, as it enrolled only 134 hospitalized children.19  Pediatric obesity has previously been associated with risk of respiratory failure in a variety of settings, including sedations and operations.2629  Despite this literature, child weight status was not included as a potential predictor in a recent risk prediction model for pneumonia severity of illness; it should be considered to improve risk stratification in the future.30  Awareness of both underweight and obesity as risk factors for severe disease could help clinicians making decisions about patient triage, monitoring, and disposition.

For the outcomes of ICU admission and hospital LOS, we found stronger associations with underweight compared to overweight or obesity. These findings could reflect confounding by malnutrition, recent illness, or complex conditions not captured in the Pediatric Medical Complexity Algorithm used, although our study was not designed specifically to investigate these mechanisms. Similar associations between underweight and disease severity have been found previously in children hospitalized in Japan for influenza-related respiratory infections and respiratory syncytial virus after excluding patients with medical complexity.31,32  Underweight could be associated with malnutrition or micronutrient deficiencies; vitamin D deficiency may be associated with poor outcomes from sepsis and respiratory illness in children, and zinc supplementation may reduce risk of mortality from pneumonia.33,34  Further research is necessary to understand the varied mechanisms behind these associations and mitigate poor outcomes in this population.

The existing literature on pediatric obesity and asthma is inconsistent; therefore, we performed a subgroup analysis of children with a primary diagnosis of asthma to further investigate these associations. Our findings in this cohort were similar to the overall cohort, specifically an increased need for positive pressure respiratory support and ICU admission with increasing weight category; additionally, we found a positive association between LOS and increasing weight category in this cohort. Multiple single-site studies have produced contradictory results on associations between obesity and LOS or ICU admission911,35  One national study using the Kids’ Inpatient Database relied on administrative codes for the definition of obesity and did find associations with mechanical ventilation and longer hospital length of stay for children admitted with asthma.14  Our study validates this finding with the use of measured height and weight. In contrast, a single-center study conducted over 1 year found that obesity had minimal association with LOS or ICU admission in children hospitalized with status asthmaticus.9  Our multiyear, multicenter study represents a significant improvement in terms of statistical power and generalizability compared with this existing literature. It has been suggested that pediatric obesity-related asthma is a distinct asthma phenotype with increased morbidity and impaired response to common asthma medications36,37 ; in our study, we did see increased reliance on advanced respiratory support in this population, but we did not specifically assess medication response. Our findings suggest that clinicians should consider a patient’s weight when triaging children presenting with respiratory illness, especially given known underrecognition of obesity in the inpatient setting.1517  Future research on health outcome disparities and underlying mechanisms directing health outcomes for children with underweight, overweight, or obesity could inform evidence-based guidelines specific to the inpatient management of these populations.

This study used measured anthropometric data from multiple sites across the United States to investigate associations between weight and respiratory disease outcomes. The prevalence of obesity in our study is very similar to the prevalence of 20.6% previously noted for children hospitalized for infectious causes, providing further reassurance about the generalizability of our findings.38  However, our study should be interpreted in light of several limitations. All sites included in the PEDSnet database are children’s hospitals, so results may not be generalizable to all institutions providing care for children. A significant proportion of all potential encounters in the PEDSnet database had missing height data that prevented the calculation of BMI; it is possible that exclusion of these subjects could bias our analysis, although our sensitivity analysis using data from the three sites with the least missing data are reassuring. Even with measured height and weight, BMI is an imperfect measure of adiposity and may not accurately represent body composition for all patients.39,40  Our cohort was defined using diagnosis codes for respiratory disease, which may result in misclassification of some patients. Most notably, changes in the designation of a primary diagnosis code over time may have complicated our subgroup analysis of children with a primary diagnosis of asthma.41  Furthermore, associations between weight categorization and clinical outcomes could vary with different specific infections (ie, coronavirus disease 2019, pandemic influenza A [H1N1]), which we did not assess in this study.4244  The cohort was defined using children initially seen in an ED, thus excluding those directly admitted to the hospital. Despite the use of electronic health record data in the PEDSnet data set, there were some variables of interest for which we were unable to obtain granular data (ie, supplemental oxygen via nasal cannula). For children who did require positive pressure ventilation, we have limited information about the reasons for their respiratory failure. ICU admission was another primary outcome; however, indications for ICU admission could vary between institutions. Socioeconomic status could be a significant confounder in the association between weight status and the outcomes assessed in this study. Payer was the only available proxy but may not be an ideal measure of socioeconomic status, which could contribute to residual confounding; our study was not well-positioned to evaluate potential associations between social determinants of health and hospital outcomes. Finally, even in this large, multisite cohort, a relatively small number of children with class 2 and 3 obesity may have limited our power to identify associations in these populations.

Among children evaluated for lower respiratory tract disease, both underweight and overweight or obesity are associated with increased respiratory support and ICU admission in hospitalized children. Further research is needed to understand these associations and their underlying mechanisms, with the goal of improving clinical outcomes for all children.

FUNDING: No external funding.

CONFLICT OF INTEREST DISCLOSURES: The authors have indicated they have no conflicts of interest relevant to this work to disclose.

Dr Halvorson conceptualized and designed the study, carried out the analyses, and drafted the initial manuscript; Drs Saha and Forrest and Ms Razzaghi assisted with data analysis and interpretation and reviewed and revised the manuscript; Drs Brittan, Christakis, Cole, Mejias, Phan, McCrory, Wells, Skelton, Poehling, and Tieder assisted with the study design and interpretation of results and reviewed and revised the manuscript; and all authors approved the final manuscript as submitted and agree to be accountable for all aspects of the work

1.
Hales
CM
,
Carroll
MD
,
Fryar
CD
,
Ogden
CL
.
Prevalence of obesity among adults and youth: United States, 2015-2016
.
NCHS Data Brief
.
2017
; (
288
):
1
8
2.
Skinner
AC
,
Ravanbakht
SN
,
Skelton
JA
,
Perrin
EM
,
Armstrong
SC
.
Prevalence of obesity and severe obesity in US children, 1999-2016
.
Pediatrics
.
2018
;
141
(
3
):
e20173459
3.
Chisti
MJ
,
Tebruegge
M
,
La Vincente
S
,
Graham
SM
,
Duke
T
.
Pneumonia in severely malnourished children in developing countries - mortality risk, aetiology and validity of WHO clinical signs: a systematic review
.
Trop Med Int Health
.
2009
;
14
(
10
):
1173
1189
4.
Skinner
AC
,
Steiner
MJ
,
Henderson
FW
,
Perrin
EM
.
Multiple markers of inflammation and weight status: cross-sectional analyses throughout childhood
.
Pediatrics
.
2010
;
125
(
4
):
e801
e809
5.
Forno
E
,
Han
YY
,
Mullen
J
,
Celedón
JC
.
Overweight, obesity, and lung function in children and adults-A meta-analysis
.
J Allergy Clin Immunol Pract
.
2018
;
6
(
2
):
570
581.e10
6.
Halvorson
EE
,
Curley
T
,
Wright
M
,
Skelton
JA
.
Weight bias in pediatric inpatient care
.
Acad Pediatr
.
2019
;
19
(
7
):
780
786
7.
Kelly
AS
,
Barlow
SE
,
Rao
G
, et al
;
American Heart Association Atherosclerosis, Hypertension, and Obesity in the Young Committee of the Council on Cardiovascular Disease in the Young, Council on Nutrition, Physical Activity and Metabolism, and Council on Clinical Cardiology
.
Severe obesity in children and adolescents: identification, associated health risks, and treatment approaches: a scientific statement from the American Heart Association
.
Circulation
.
2013
;
128
(
15
):
1689
1712
8.
Aragona
E
,
El-Magbri
E
,
Wang
J
, et al
.
Impact of obesity on clinical outcomes in urban children hospitalized for status asthmaticus
.
Hosp Pediatr
.
2016
;
6
(
4
):
211
218
9.
Bettenhausen
J
,
Puls
H
,
Queen
MA
, et al
.
Childhood obesity and in-hospital asthma resource utilization
.
J Hosp Med
.
2015
;
10
(
3
):
160
164
10.
Carroll
CL
,
Bhandari
A
,
Zucker
AR
,
Schramm
CM
.
Childhood obesity increases duration of therapy during severe asthma exacerbations
.
Pediatr Crit Care Med
.
2006
;
7
(
6
):
527
531
.
11.
Gross
E
,
Lee
DS
,
Hotz
A
,
Ngo
KC
,
Rastogi
D
.
Impact of obesity on asthma morbidity during a hospitalization
.
Hosp Pediatr
.
2018
;
8
(
9
):
538
546
12.
Berdahl
T
,
Biener
A
,
McCormick
MC
,
Guevara
JP
,
Simpson
L
.
Annual report on children’s healthcare: healthcare access and utilization by obesity status in the United States
.
Acad Pediatr
.
2020
;
20
(
2
):
175
187
13.
Okubo
Y
,
Nochioka
K
,
Testa
MA
.
The impact of pediatric obesity on hospitalized children with lower respiratory tract infections in the United States
.
Clin Respir J
.
2018
;
12
(
4
):
1479
1484
14.
Okubo
Y
,
Nochioka
K
,
Hataya
H
,
Sakakibara
H
,
Terakawa
T
,
Testa
M
.
Burden of obesity on pediatric inpatients with acute asthma exacerbation in the United States
.
J Allergy Clin Immunol Pract
.
2016
;
4
(
6
):
1227
1231
15.
King
MA
,
Nkoy
FL
,
Maloney
CG
,
Mihalopoulos
NL
.
Physicians and physician trainees rarely identify or address overweight/obesity in hospitalized children
.
J Pediatr
.
2015
;
167
(
4
):
816
820.e1
16.
Woo
JG
,
Zeller
MH
,
Wilson
K
,
Inge
T
.
Obesity identified by discharge ICD-9 codes underestimates the true prevalence of obesity in hospitalized children
.
J Pediatr
.
2009
;
154
(
3
):
327
331
17.
Katzow
M
,
Homel
P
,
Rhee
K
.
Factors associated with documentation of obesity in the inpatient setting
.
Hosp Pediatr
.
2017
;
7
(
12
):
731
738
18.
Bailey
LC
,
Milov
DE
,
Kelleher
K
, et al
.
Multi-institutional sharing of electronic health record data to assess childhood obesity
.
PLoS One
.
2013
;
8
(
6
):
e66192
19.
Halvorson
EE
,
Peters
TR
,
Skelton
JA
,
Suerken
C
,
Snively
BM
,
Poehling
KA
.
Is weight associated with severity of acute respiratory illness?
Int J Obes
.
2018
;
42
(
9
):
1582
1589
20.
Greenbaum
AH
,
Chen
J
,
Reed
C
, et al
.
Hospitalizations for severe lower respiratory tract infections
.
Pediatrics
.
2014
;
134
(
3
):
546
554
21.
Williams
DJ
,
Shah
SS
,
Myers
A
, et al
.
Identifying pediatric community-acquired pneumonia hospitalizations: Accuracy of administrative billing codes
.
JAMA Pediatr
.
2013
;
167
(
9
):
851
858
22.
Simon
TD
,
Haaland
W
,
Hawley
K
,
Lambka
K
,
Mangione-Smith
R
.
Development and validation of the Pediatric Medical Complexity Algorithm (PMCA) Version 3.0
.
Acad Pediatr
.
2018
;
18
(
5
):
577
580
23.
Kuczmarski
RJ
,
Ogden
CL
,
Guo
SS
, et al
.
2000 CDC Growth Charts for the United States: methods and development
.
Vital Health Stat 11
.
2002
; (
246
):
1
190
24.
Ogden
CL
,
Flegal
KM
.
Changes in terminology for childhood overweight and obesity
.
Natl Health Stat Rep
.
2010
; (
25
):
1
5
25.
Freedman
DS
,
Lawman
HG
,
Pan
L
, et al
.
The prevalence and validity of high, biologically implausible values of weight, height, and BMI among 8.8 million children
.
Obesity (Silver Spring)
.
2016
;
24
(
5
):
1132
1139
26.
Fung
E
,
Cave
D
,
Witmans
M
,
Gan
K
,
El-Hakim
H
.
Postoperative respiratory complications and recovery in obese children following adenotonsillectomy for sleep-disordered breathing: a case-control study
.
Otolaryngol Head Neck Surg
.
2010
;
142
(
6
):
898
905
27.
Tait
AR
,
Voepel-Lewis
T
,
Burke
C
,
Kostrzewa
A
,
Lewis
I
.
Incidence and risk factors for perioperative adverse respiratory events in children who are obese
.
Anesthesiology
.
2008
;
108
(
3
):
375
380
28.
Ross
E
,
Burris
A
,
Murphy
JT
.
Obesity and outcomes following burns in the pediatric population
.
J Pediatr Surg
.
2014
;
49
(
3
):
469
473
29.
Grunwell
JR
,
McCracken
C
,
Fortenberry
J
,
Stockwell
J
,
Kamat
P
.
Risk factors leading to failed procedural sedation in children outside the operating room
.
Pediatr Emerg Care
.
2014
;
30
(
6
):
381
387
30.
Williams
DJ
,
Zhu
Y
,
Grijalva
CG
, et al
.
Predicting severe pneumonia outcomes in children
.
Pediatrics
.
2016
;
138
(
4
):
e20161019
31.
Okubo
Y
,
Morisaki
N
,
Michihata
N
,
Matsui
H
,
Fushimi
K
,
Yasunaga
H
.
Dose-dependent relationships between weight status and clinical outcomes among infants hospitalized with respiratory syncytial virus infections
.
Pediatr Pulmonol
.
2018
;
53
(
4
):
461
466
32.
Okubo
Y
,
Michihata
N
,
Uda
K
, et al
.
Dose-response relationship between weight status and clinical outcomes in pediatric influenza-related respiratory infections
.
Pediatr Pulmonol
.
2018
;
53
(
2
):
218
223
33.
Cariolou
M
,
Cupp
MA
,
Evangelou
E
,
Tzoulaki
I
,
Berlanga-Taylor
AJ
.
Importance of vitamin D in acute and critically ill children with subgroup analyses of sepsis and respiratory tract infections: a systematic review and meta-analysis
.
BMJ Open
.
2019
;
9
(
5
):
e027666
34.
Wang
L
,
Song
Y
.
Efficacy of zinc given as an adjunct to the treatment of severe pneumonia: A meta-analysis of randomized, double-blind and placebo-controlled trials
.
Clin Respir J
.
2018
;
12
(
3
):
857
864
35.
Parlar-Chun
R
,
Truong
G
,
Isbell
T
,
Delgado
Y
,
Arca
M
.
Association of obesity with severity outcomes in hospitalized pediatric asthma exacerbations
.
The Journal of asthma: official journal of the Association for the Care of Asthma
.
2020
:
1
5
.
36.
Rastogi
D
,
Holguin
F
.
Metabolic dysregulation, systemic inflammation, and pediatric obesity-related asthma
.
Ann Am Thorac Soc
.
2017
;
14
(
Supplement_5
):
S363
S367
37.
Rastogi
D
.
Pediatric obesity-related asthma: A prototype of pediatric severe non-T2 asthma
.
Pediatr Pulmonol
.
2020
;
55
(
3
):
809
817
38.
Kyler
KE
,
Bettenhausen
JL
,
Hall
M
,
Hampl
S
.
Prevalence and trends in obesity among hospitalized children
.
Hosp Pediatr
.
2019
;
9
(
11
):
897
902
39.
Demerath
EW
,
Schubert
CM
,
Maynard
LM
, et al
.
Do changes in body mass index percentile reflect changes in body composition in children? Data from the Fels Longitudinal Study
.
Pediatrics
.
2006
;
117
(
3
):
e487
e495
40.
Telford
RD
,
Cunningham
RB
,
Abhayaratna
WP
.
Temporal divergence of percent body fat and body mass index in pre-teenage children: the LOOK longitudinal study
.
Pediatr Obes
.
2014
;
9
(
6
):
448
454
41.
Willer
RJ
,
Coon
ER
,
Harrison
WN
,
Ralston
SL
.
Trends in hospital costs and levels of services provided for children with bronchiolitis treated in children’s hospitals
.
JAMA Netw Open
.
2021
;
4
(
10
):
e2129920
42.
Chen
WH
,
Lu
CY
,
Shao
PL
, et al
.
Risk factors of severe novel influenza A (H1N1) infections in hospitalized children
.
J Formos Med Assoc
.
2012
;
111
(
8
):
421
426
43.
Plessa
E
,
Diakakis
P
,
Gardelis
J
,
Thirios
A
,
Koletsi
P
,
Falagas
ME
.
Clinical features, risk factors, and complications among pediatric patients with pandemic influenza A (H1N1)
.
Clin Pediatr (Phila)
.
2010
;
49
(
8
):
777
781
44.
Tripathi
S
,
Christison
AL
,
Levy
E
, et al
;
Society of Critical Care Medicine Discovery Viral Infection and Respiratory Illness Universal Study (VIRUS): COVID-19 Registry Investigator Group
.
The impact of obesity on disease severity and outcomes among hospitalized children with COVID-19
.
Hosp Pediatr
.
2021
;
11
(
11
):
e297
e316

Supplementary data